Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

The Original Article was published on 03 August 2020

Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-1008-z, published online 3 August 2020.

In the version of this article initially published, the affiliation provided for author Matteo Giovanni Della Porta (37Cancer Center, Humanitas Research Hospital & Humanitas University, Milan, Italy) was incorrect, and a second affiliation was missing. The correct affiliations are as follows (with subsequent affiliations renumbered accordingly): 37Humanitas Clinical and Research Center–IRCCS, Humanitas Cancer Center, Milan, Italy. 38Department of Biomedical Sciences, Humanitas University, Milan, Italy. The errors have been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Elli Papaemmanuil.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bernard, E., Nannya, Y., Hasserjian, R.P. et al. Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med 27, 562 (2021). https://doi.org/10.1038/s41591-021-01253-5

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing